FAL IP The iPhone X has now been announced by Apple, Inc. (‘Apple’) with expected fanfare. Most consumers will be interested in the new OLED screen and the elimination of the home button in the new iPhone X, but there is also an important new security feature in the new iPhone called ‘Face ID’. ‘Face ID’ is … Read more
For the third consecutive year, we are delighted to announce that Francis Abourizk Lightowlers (FAL Lawyers) founding partner, Jenni Lightowlers, has been recognised for Excellence in Client Service in the Health and Life Sciences category at the 2017 International Law Office (ILO) and Lexology Client Choice Awards. She is once again the only lawyer in … Read more
Congratulations to FAL’s founding Partner, Jenni Lightowlers, who was awarded an Honorary Doctorate from Deakin University on 6 October 2016. Honorary degrees are conferred by the University Council following consideration by the Honorary Degrees Committee. The Honorary Doctorate acknowledges Jenni’s outstanding service to Deakin University as Deputy Chancellor from 2008 to 2015, as a member … Read more
When new IP is created, the desire to get it ‘out there’ is understandable. This is particularly so where the IP requires further development, has commercial potential, or originates from a researcher with a public benefit mandate. In the eagerness to license the IP, it is important to ensure that for all licences to rights … Read more
We are delighted to announce that FAL’s founding partner, Jenni Lightowlers, has been recognised for Excellence in Client Service in the Health and Life Sciences at the 2016 International Law Office (ILO) and Lexology Client Choice Awards. This is the second year running Jenni has won the award. The Lexology Client Choice Awards recognise those partners around … Read more
On September 2 2015 the High Court handed down a widely anticipated decision in AstraZeneca AB v Aptoex Pty Ltd.(1) The court unanimously dismissed AstraZeneca’s appeal, holding that AstraZeneca’s patent was invalid because it was obvious and therefore lacked the requisite inventive step within Sections 7(2) and 7(3) of the Patents Act 1990. Facts Compounds known … Read more
